Cyclin-dependent kinase 11p110 (CDK11p110) is crucial for human breast cancer cell proliferation and growth
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cyclin-dependent kinase 11p110 (CDK11p110) is crucial for human breast cancer cell proliferation and growth
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-05-20
DOI
10.1038/srep10433
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Flavopiridol Synergizes with Sorafenib to Induce Cytotoxicity and Potentiate Antitumorigenic Activity in EGFR/HER-2 and Mutant RAS/RAF Breast Cancer Model Systems
- (2015) Teddy S Nagaria et al. NEOPLASIA
- CDK11p58inhibits ERα-positive breast cancer invasion by targeting integrin β3 via the repression of ERα signaling
- (2014) Yayun Chi et al. BMC CANCER
- Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
- (2014) Patricia A.J. Muller et al. CANCER CELL
- CDK 4/6 Inhibitors Sensitize PIK3CA Mutant Breast Cancer to PI3K Inhibitors
- (2014) Sadhna R. Vora et al. CANCER CELL
- Cyclin-dependent kinase 4 overexpression is mostly independent of gene amplification and constitutes an independent prognosticator for nasopharyngeal carcinoma
- (2014) Tzu-Ju Chen et al. TUMOR BIOLOGY
- Aberrant CDK4 Amplification in Refractory Rhabdomyosarcoma as Identified by Genomic Profiling
- (2014) Silvia Park et al. Scientific Reports
- HER2 confers drug resistance of human breast cancer cells through activation of NRF2 by direct interaction
- (2014) Hyo Jin Kang et al. Scientific Reports
- Cyclin-dependent kinases
- (2014) Marcos Malumbres GENOME BIOLOGY
- Highlights of the Latest Advances in Research on CDK Inhibitors
- (2014) Jonas Cicenas et al. Cancers
- Targeted Therapy for Breast Cancer
- (2013) Ali Mohamed et al. AMERICAN JOURNAL OF PATHOLOGY
- Everolimus in hormone receptor–positive advanced breast cancer: Targeting receptor-based mechanisms of resistance
- (2013) Mikhail I. Shtivelband BREAST
- Breast cancer statistics, 2013
- (2013) Carol DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cyclin-dependent kinase 11 (CDK11) is crucial in the growth of liposarcoma cells
- (2013) Bin Jia et al. CANCER LETTERS
- LPS-Stimulating Astrocyte-Conditioned Medium Causes Neuronal Apoptosis Via Increasing CDK11p58 Expression in PC12 Cells Through Downregulating AKT Pathway
- (2013) Xiaojuan Liu et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Dual CDK4/CDK6 Inhibition Induces Cell-Cycle Arrest and Senescence in Neuroblastoma
- (2013) J. Rader et al. CLINICAL CANCER RESEARCH
- Effects ofTP53mutational status on gene expression patterns across 10 human cancer types
- (2013) Neha Parikh et al. JOURNAL OF PATHOLOGY
- Targeting cell cycle regulation in cancer therapy
- (2013) Santiago Diaz-Moralli et al. PHARMACOLOGY & THERAPEUTICS
- CDK5 is essential for TGF-β1-induced epithelial-mesenchymal transition and breast cancer progression
- (2013) Qian Liang et al. Scientific Reports
- Targeting triple-negative breast cancer: optimising therapeutic outcomes
- (2012) K. Gelmon et al. ANNALS OF ONCOLOGY
- Cyclin dependent kinases in cancer
- (2012) Miriam Canavese et al. CANCER BIOLOGY & THERAPY
- Systematic Kinome shRNA Screening Identifies CDK11 (PITSLRE) Kinase Expression Is Critical for Osteosarcoma Cell Growth and Proliferation
- (2012) Z. Duan et al. CLINICAL CANCER RESEARCH
- p53 mutations in cancer
- (2012) Patricia A. J. Muller et al. NATURE CELL BIOLOGY
- Cdk11-CyclinL Controls the Assembly of the RNA Polymerase II Mediator Complex
- (2012) Julie Drogat et al. Cell Reports
- RETRACTED: Polypyrimidine tract-binding protein regulates the cell cycle through IRES-dependent translation of CDK11p58 in mouse embryonic stem cells
- (2011) Satona Ohno et al. CELL CYCLE
- The RNA Binding Motif Protein 15B (RBM15B/OTT3) Is a Functional Competitor of Serine-Arginine (SR) Proteins and Antagonizes the Positive Effect of the CDK11p110-Cyclin L2α Complex on Splicing
- (2010) Pascal Loyer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen-induced phosphorylation of ER-α in human ER-positive breast cancer cells
- (2010) Józefa Węsierska-Gądek et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Amplification of CyclinL1 in uterine cervical carcinoma has prognostic implications
- (2010) Sraboni Mitra et al. MOLECULAR CARCINOGENESIS
- Mutant p53 mediates survival of breast cancer cells
- (2009) L Y Lim et al. BRITISH JOURNAL OF CANCER
- Cyclin-dependent kinases: a family portrait
- (2009) Marcos Malumbres et al. NATURE CELL BIOLOGY
- Characterization of Cyclin L1 and L2 Interactions with CDK11 and Splicing Factors
- (2008) Pascal Loyer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started